Bodyflight Sweden AB Statistics
Total Valuation
XSAT:BODY has a market cap or net worth of SEK 12.73 million. The enterprise value is 26.10 million.
Market Cap | 12.73M |
Enterprise Value | 26.10M |
Important Dates
The last earnings date was Thursday, August 28, 2025.
Earnings Date | Aug 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
XSAT:BODY has 16.75 million shares outstanding.
Current Share Class | 16.75M |
Shares Outstanding | 16.75M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 16.90% |
Owned by Institutions (%) | n/a |
Float | 9.98M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.50 |
PB Ratio | 0.25 |
P/TBV Ratio | 0.26 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -5.37 |
EV / Sales | 1.03 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -2.89 |
Financial Position
The company has a current ratio of 0.29, with a Debt / Equity ratio of 0.28.
Current Ratio | 0.29 |
Quick Ratio | 0.21 |
Debt / Equity | 0.28 |
Debt / EBITDA | 65.37 |
Debt / FCF | -1.60 |
Interest Coverage | -2.37 |
Financial Efficiency
Return on equity (ROE) is -9.10% and return on invested capital (ROIC) is -3.01%.
Return on Equity (ROE) | -9.10% |
Return on Assets (ROA) | -2.20% |
Return on Invested Capital (ROIC) | -3.01% |
Return on Capital Employed (ROCE) | -4.33% |
Revenue Per Employee | 1.41M |
Profits Per Employee | -270,278 |
Employee Count | 20 |
Asset Turnover | 0.28 |
Inventory Turnover | 73.25 |
Taxes
Income Tax | -58,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.54% in the last 52 weeks. The beta is 0.55, so XSAT:BODY's price volatility has been lower than the market average.
Beta (5Y) | 0.55 |
52-Week Price Change | -41.54% |
50-Day Moving Average | 0.57 |
200-Day Moving Average | 0.87 |
Relative Strength Index (RSI) | 56.46 |
Average Volume (20 Days) | 26,352 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XSAT:BODY had revenue of SEK 25.35 million and -4.87 million in losses. Loss per share was -0.29.
Revenue | 25.35M |
Gross Profit | 12.35M |
Operating Income | -3.23M |
Pretax Income | -5.06M |
Net Income | -4.87M |
EBITDA | 221,000 |
EBIT | -3.23M |
Loss Per Share | -0.29 |
Balance Sheet
The company has 1.07 million in cash and 14.45 million in debt, giving a net cash position of -13.38 million or -0.80 per share.
Cash & Cash Equivalents | 1.07M |
Total Debt | 14.45M |
Net Cash | -13.38M |
Net Cash Per Share | -0.80 |
Equity (Book Value) | 51.53M |
Book Value Per Share | 3.08 |
Working Capital | -10.64M |
Cash Flow
In the last 12 months, operating cash flow was -4.67 million and capital expenditures -4.36 million, giving a free cash flow of -9.03 million.
Operating Cash Flow | -4.67M |
Capital Expenditures | -4.36M |
Free Cash Flow | -9.03M |
FCF Per Share | -0.54 |
Margins
Gross margin is 48.72%, with operating and profit margins of -12.74% and -19.19%.
Gross Margin | 48.72% |
Operating Margin | -12.74% |
Pretax Margin | -19.94% |
Profit Margin | -19.19% |
EBITDA Margin | 0.87% |
EBIT Margin | -12.74% |
FCF Margin | n/a |
Dividends & Yields
XSAT:BODY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -38.22% |
FCF Yield | -70.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
XSAT:BODY has an Altman Z-Score of 1.03 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.03 |
Piotroski F-Score | 2 |